Kamil Sedlacek

Kamil Sedlacek

Czech Republic

 

 

 

 

Kamil Sedláček, M.D.
Born: June 6, 1974, Brno, Czech Republic
Medical education and positions held
1992 – 1998: 1st Medical Faculty, Charles University, Prague. Graduation 1998 (M.D.)
Sept 1996: Elective in Wytham Hall Hospital in London (general practice, social medicine)
Oct 1998 – June 2001: Internal medicine residency at the 2nd Clinic of Medicine, Charles University, Prague.
Sept 2003 – Oct 2004: fellow in Cardiology, 2nd Clinic of Medicine, Charles University, Prague.
Nov 2004-Dec 2006: fellow in Internal medicine and Cardiology, 2nd Clinic of Medicine,
University of Regensburg, Germany
Jan – Oct 2007: fellow in cardiology, Dptm. Of Cardiology, District hospital in Pardubice, Czech Republic
Since Nov 2007: Fellow in cardiology and cardiac electrophysiology, Clinic of Cardiology IKEM, Prague, Czech Republic
December 2007: Board Licence in Internal Medicine
Dec 2008: Cardiology Board Exam
Since 2010: Head of the Cardiac electrophysiology device and lead management program at IKEM, Prague
Research
Jul 2001 – July 2003: 2nd Clinic of Medicine, University of Regensburg, Germany and GSF National Research Centre, Munich Germany. Research topic: Genetics of myocardial infarction; identification of myocardial infarction susceptibility genes.
Nov 2004-Dec 2006: 2nd Clinic of Medicine, University of Regensburg, Germany. Research topic: Genetics of myocardial infarction, life-threatening cardiac arrhythmias and sudden cardiac death
Since Nov 2007: Clinic of cardiology, IKEM, Prague, Czech Republic. Research topic: Cardiac resynchronization therapy in patients with heart failure.
Language skills
fluent spoken and written English and German
Research articles in peer-reviewed journals
1.Sedmera D, Neckar J, Benes J Jr, Pospisilova J, Petrak J, Sedlacek K, Melenovsky V. Changes in Myocardial Composition and Conduction Properties in Rat Heart Failure Model Induced by Chronic Volume Overload. Front Physiol. 2016 Aug 25;7:367.
2. Sedláček K, Ruwald AC, Kutyifa V, McNitt S, Thomsen PE, Klein H, Stockburger M, Wichterle D, Merkely B, DE LA Concha JF, Swissa M, Zareba W, Moss AJ, Kautzner J, Ruwald MH; MADIT-RIT Investigators. The effect of ICD programming on inappropriate and appropriate ICD Therapies in ischemic and nonischemic cardiomyopathy: the MADIT-RIT trial. J Cardiovasc Electrophysiol. 2015 Apr;26(4):424-33.
3. Stefan L, Sedláček K, Černá D, Krýže L, Vančura V, Marek T, Kautzner J. Small left atrium and mild mitral regurgitation predict super-response to cardiac resynchronization therapy. Europace. 2012 Nov;14(11):1608-14.
4. Di Biase L, Auricchio A, Mohanty P, Bai R, Kautzner J, Pieragnoli P, Regoli F, Sorgente A, Spinucci G, Ricciardi G, Michelucci A, Perrotta L, Faletra F, Mlcochová H, Sedlacek K, Canby R, Sanchez JE, Horton R, Burkhardt JD, Moccetti T, Padeletti L, Natale A. Impact of cardiac resynchronization therapy on the severity of mitral regurgitation. Europace. 2011 Jun;13(6):829-38.
5. Sedláček K, Burianová L, Mlčochová H, Peichl P, Marek T, Kautzner J. Isolated left ventricular pacing results in worse long-term clinical outcome when compared with biventricular pacing: a single-centre randomized study. Europace. 2010 Dec;12(12):1762-8.
6. Sedlacek K, Stark K, Cunha SR, Pfeufer A, Weber S, Berger I, Perz S, Kääb S, Wichmann HE, Mohler PJ, Hengstenberg C, Jeron A. Common genetic variants in ANK2 modulate QT interval: results from the KORA study. Circ Cardiovasc Genet. 2008 Dec;1(2):93-9.
7. Reinhard W, Stark K, Neureuther K, Sedlacek K, Fischer M, Baessler A, Weber S,
Kaess B, Wiedmann S, Erdmann J, Lieb W, Jeron A, Riegger G, Hengstenberg C.
Common polymorphisms in the cannabinoid CB2 receptor gene (CNR2) are not
associated with myocardial infarction and cardiovascular risk factors. Int J Mol
Med. 2008 Aug;22(2):165-74.
8. Stark K, Reinhard W, Neureuther K, Wiedmann S, Sedlacek K, Baessler A, Fischer M, Weber S, Kaess B, Erdmann J, Schunkert H, Hengstenberg C. Association of common polymorphisms in GLUT9 gene with gout but not with coronary artery disease in a large case-control study. PLoS One. 2008 Apr 9;3(4):e1948.
9. Reinhard W, Stark K, Sedlacek K, Fischer M, Baessler A, Neureuther K, Weber S, Kaess B, Wiedmann S, Mitsching S, Lieb W, Erdmann J, Meisinger C, Doering A, Tolle R, Jeron A, Riegger G, Hengstenberg C. Association between PPARalpha gene polymorphisms and myocardial infarction. Clin Sci (Lond). 2008 Nov;115(10):301-8.
10. Aschermann M, Sedlácek K, Aschermann O, Linhart A. Molecular genetics of myocardial infarction. Vnitr Lek. 2007 Apr;53(4):348-53.
11. Sedlacek K, Neureuther K, Mueller JC, Stark K, Fischer M, Baessler A, Reinhard W, Broeckel U, Lieb W, Erdmann J, Schunkert H, Riegger G, Illig T, Meitinger T, Hengstenberg C. Lymphotoxin-alpha and galectin-2 SNPs are not associated with myocardial infarction in two different German populations. J Mol Med (Berl). 2007 Sep;85(9):997-1004.
12. Stark K, Neureuther K, Sedlacek K, Hengstenberg W, Fischer M, Baessler A, Wiedmann S, Jeron A, Holmer S, Erdmann J, Schunkert H, Hengstenberg C. The common Y402H variant in complement factor H gene is not associated with susceptibility to myocardial infarction and its related risk factors. Clin Sci (Lond). 2007 Aug;113(4):213-8.
13. Sedlácek K, Fischer M, Erdmann J, Hengstenberg C, Holmer S, Kürzinger S, Muscholl M, Luchner A, Riegger GA, Hense HW, Schunkert H. Relation of the G protein beta3-subunit polymorphism with left ventricle structure and function. Hypertension. 2002 Aug;40(2):162-7.
14. Linhart A, Jindra A, Golán L, Jáchymová M, Sedlácek K, Peleska J, Umnerová V, Bultas J, Horký K, Aschermann M. Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men. Br J Biomed Sci. 2002;59(2):90-4.
15. Linhart A, Jindra A, Goláň L, Jáchymová M, Sedláček K, Peleška J, Umnerová V, Bultas J, Horky K, Aschermann M. Association between tyrosine hydroxylase polymorphisms and left ventricular structure in young normotensive men. Br J Biomed Sci. 2002 Jan;59(2):90-94.
16: Linhart A, Sedláček K, Jáchymová M, Jindra A, Beran S, Vondráček V, Heller S, Horký K. Lack of Association of Angiotensin-converting Enzyme and Angiotensinogen Genes Polymorphisms with Left Ventricular Structure in Young Normotensive Men. Blood Press. 2000;9(1):47-51.